CFX NYSE

Colfax Corporation operates as a global, diversified technology enterprise, structured into two primary divisions: Fabrication Technology and Medical Technology. The Fabrication Technology division specializes in the formulation, development, manufacturing, and supply of consumable products and associated equipment. These are crucial for industrial applications such as cutting, joining, automated welding, and gas flow control. Its comprehensive product portfolio includes a variety of welding consumables, like electrodes, wires, and fluxes, alongside cutting consumables such as nozzles, shields, and tips. These items are distributed through independent channels and direct sales to diverse markets, including general industry, construction, infrastructure, transportation, energy, and medical and life sciences, predominantly under the ESAB brand. Conversely, the Medical Technology division is dedicated to the development, production, and distribution of advanced medical devices. These devices are utilized by a broad spectrum of healthcare practitioners, including orthopedic specialists, surgeons, physical therapists, and athletic trainers, to manage musculoskeletal conditions caused by degenerative diseases, deformities, traumatic incidents, and sports-related injuries. Its extensive product offerings encompass rigid and soft orthopedic bracing, hot and cold therapy systems, bone growth stimulators, vascular therapy solutions, therapeutic footwear, electrical stimulators for pain management, and a full range of reconstructive joint implants for areas like the hip, knee, and shoulder. Sales for this segment, primarily under the DJO brand, occur via independent distributors (such as healthcare professionals and retail pharmacies) and direct channels. Established in 1860, Colfax Corporation is headquartered in Wilmington, Delaware.